Retatrutide
Initial concentration for baseline titration studies.
Retatrutide (LY3437943) triple hormone receptor agonist research peptide. Targeted for GIP, GLP-1, and glucagon receptor pathway investigations. Often referred to as the 'next-generation' metabolic research compound. For laboratory research use only.
Secure checkout and fulfillment via Particle Peptides (Official 2026 Partner).
SKU: BBL-45-5mg
Fulfillment: Direct from Particle Peptides EU
Product Overview
Retatrutide (LY3437943) triple hormone receptor agonist research peptide. Targeted for GIP, GLP-1, and glucagon receptor pathway investigations. Often referred to as the 'next-generation' metabolic research compound. For laboratory research use only.
This research-grade peptide is distributed in partnership with Particle Peptides to ensure maximum freshness and rapid delivery. Each batch undergoes rigorous third-party testing including HPLC and mass spectrometry.
Alternative Research Intensities
*Independent research variants for specific volumetric study parameters.
Related Research Peptides
Tirzepatide
Tirzepatide research compound. Dual GLP-1/GIP receptor agonist used in metabolic pathway research and incretin hormone studies. For qualified researchers conducting scientific experiments only.
AOD9604
AOD9604 research peptide. Modified growth hormone fragment for lipolysis and lipid metabolism studies. Used in fat metabolism research without affecting glucose homeostasis. For laboratory research purposes only.
Semaglutide 2mg
Standard maintenance concentration for established research protocols. GLP-1 receptor agonist peptide used in metabolic pathway research and glucose regulation studies.
Semaglutide 5mg
Premium strength for advanced research protocols and maximum pathway investigation.
€89
Partner Stock